Jacqueline Claire Lupo
Chief Executive Officer bei LOPHOS HOLDINGS INC.
Vermögen: 660 000 $ am 30.04.2024
Profil
Jacqueline Claire Lupo is the founder of Lophos Pharmaceuticals Corp., where she holds the title of President, CEO & Director since 2021.
She is also the founder of Canalytica Corp.
Ms. Lupo's current job is as the Chief Executive Officer & Director at Lophos Holdings, Inc. since 2021.
Additionally, she is currently working as a Manager at Northern Green Canada, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LOPHOS HOLDINGS, INC.
14,90% | 12.02.2024 | 11 000 000 ( 14,90% ) | 660 000 $ | 30.04.2024 |
Aktive Positionen von Jacqueline Claire Lupo
| Unternehmen | Position | Beginn |
|---|---|---|
| LOPHOS HOLDINGS INC. | Chief Executive Officer | 23.12.2021 |
Lophos Pharmaceuticals Corp.
 Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The private company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Founder | 01.01.2021 |
| Northern Green Canada, Inc. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jacqueline Claire Lupo
| Unternehmen | Position | Ende |
|---|---|---|
| Canalytica Corp. | Founder | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LOPHOS HOLDINGS INC. | Process Industries |
| Private Unternehmen | 3 |
|---|---|
| Northern Green Canada, Inc. | Consumer Non-Durables |
Lophos Pharmaceuticals Corp.
Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The private company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Health Technology |
| Canalytica Corp. |
